We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
-$2.73M
Cap. Flow %
-2.16%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$7.18M
2
BIIB icon
Biogen
BIIB
+$4.33M
3
CALM icon
Cal-Maine
CALM
+$3.64M
4
AAPL icon
Apple
AAPL
+$2.74M
5
ALR
Alere Inc
ALR
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 42.49%
2 Miscellaneous 37.27%
3 Consumer Staples 5.72%
4 Consumer Discretionary 5.23%
5 Technology 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDCC icon
401
CALL
InterDigital
IDCC
$8.72B
-12,800
Closed -$37K
IDCC icon
402
PUT
InterDigital
IDCC
$8.72B
-9,800
Closed -$27K
ILMN icon
403
CALL
Illumina
ILMN
$33B
-10,280
Closed -$3K
ILMN icon
404
PUT
Illumina
ILMN
$33B
-9,149
Closed -$3K
INFY icon
405
CALL
Infosys
INFY
$47.4B
-93,600
Closed -$4K
INFY icon
406
Infosys
INFY
$47.4B
-30,714
Closed -$274K
INFY icon
407
PUT
Infosys
INFY
$47.4B
-60,000
Closed -$14K
INSM icon
408
PUT
Insmed
INSM
$27.6B
-30,000
Closed -$100K
INTC icon
409
Intel
INTC
$506B
-1,831
Closed -$64.8K
IONS icon
410
PUT
Ionis Pharmaceuticals
IONS
$9.65B
-200
Closed -$1K
IRBT
411
DELISTED
iRobot
IRBT
-5,881
Closed -$206K
IRBT
412
PUT
DELISTED
iRobot
IRBT
-6,500
Closed -$22K
JNJ icon
413
CALL
Johnson & Johnson
JNJ
$663B
-35,000
Closed -$224K
JNJ icon
414
Johnson & Johnson
JNJ
$663B
-8,606
Closed -$1.04M
JNJ icon
415
PUT
Johnson & Johnson
JNJ
$663B
-228,700
Closed -$37K
K
416
PUT
DELISTED
Kellanova
K
-42,600
Closed -$43K
KSS icon
417
CALL
Kohl's
KSS
$2.2B
-30,000
Closed -$85K
LGND icon
418
Ligand Pharmaceuticals
LGND
$5.69B
-13,573
Closed -$997K
LGND icon
419
PUT
Ligand Pharmaceuticals
LGND
$5.69B
-32,060
Closed -$189K
LLY icon
420
PUT
Eli Lilly
LLY
$1.02T
-140,000
Closed -$70K
LPCN icon
421
Lipocine
LPCN
$20.2M
-106
Closed -$5K
LPCN icon
422
PUT
Lipocine
LPCN
$20.2M
-371
Closed -$4K
LRCX icon
423
CALL
Lam Research
LRCX
$385B
-200,000
Closed -$21K
LULU icon
424
lululemon athletica
LULU
$11.1B
-3,100
Closed -$229K
LULU icon
425
PUT
lululemon athletica
LULU
$11.1B
-15,500
Closed -$56K

Similar funds

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options's Q3 2016 filing shows 153 new, 113 increased, 67 reduced and 127 closed positions. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M. The largest sale was MEDIVATION, INC., an estimated $7.18M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Miscellaneous and Consumer Staples.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.